{"title":"生殖泌尿系恶性肿瘤","authors":"Shandra S. Wilson","doi":"10.1016/j.uct.2006.08.007","DOIUrl":null,"url":null,"abstract":"<div><p>The field of Urology encompasses many diverse and divergent tumor histologies with ever-changing staging modalities and treatment algorithms. This review will focus on new developments for the major urologic malignancies including prostate, renal, bladder and testicular cancer, specifically looking at randomized, controlled studies published within the last academic year in peer-review journals.</p></div>","PeriodicalId":87487,"journal":{"name":"Update on cancer therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2006-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uct.2006.08.007","citationCount":"0","resultStr":"{\"title\":\"Genitourinary malignancies\",\"authors\":\"Shandra S. Wilson\",\"doi\":\"10.1016/j.uct.2006.08.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The field of Urology encompasses many diverse and divergent tumor histologies with ever-changing staging modalities and treatment algorithms. This review will focus on new developments for the major urologic malignancies including prostate, renal, bladder and testicular cancer, specifically looking at randomized, controlled studies published within the last academic year in peer-review journals.</p></div>\",\"PeriodicalId\":87487,\"journal\":{\"name\":\"Update on cancer therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.uct.2006.08.007\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Update on cancer therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1872115X06000570\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Update on cancer therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1872115X06000570","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The field of Urology encompasses many diverse and divergent tumor histologies with ever-changing staging modalities and treatment algorithms. This review will focus on new developments for the major urologic malignancies including prostate, renal, bladder and testicular cancer, specifically looking at randomized, controlled studies published within the last academic year in peer-review journals.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
